Not all people with CLL need therapy. Irrespective of all new advances, the iwCLL however recommends watchful observation for patients with asymptomatic condition.86 This recommendation is based on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari masyarakat dalam https://fionab975ucj1.blogozz.com/profile